{"id":10873,"date":"2021-12-21T19:51:56","date_gmt":"2021-12-21T16:51:56","guid":{"rendered":"https:\/\/roboforex.com\/blog\/?p=10873"},"modified":"2023-06-28T18:20:21","modified_gmt":"2023-06-28T15:20:21","slug":"ipo-of-candela-medical-inc-solutions-for-aesthetic-medicine","status":"publish","type":"post","link":"https:\/\/roboforex.com\/blog\/2021\/12\/21\/ipo-of-candela-medical-inc-solutions-for-aesthetic-medicine\/","title":{"rendered":"IPO of Candela Medical, Inc.: Solutions for Aesthetic Medicine"},"content":{"rendered":"\n

It is human nature to seek for better appearance and looks, and nowadays, in the time of aesthetic medicine development, people have much more opportunities to succeed. Since the late 1960s, this field of medicine has been rapidly growing in the US and Western Europe. At the same time, equipment and technologies for plastic surgeries and different dermatological procedures have also improved.<\/p>\n\n\n\n

\"IPO<\/figure>\n\n\n\n

Candela Medical, Inc., the leading supplier of equipment for aesthetic medicine, is planning an IPO<\/a> at the NASDAQ. The company’s shares will start trading the next day, (the “CDLA” ticker symbol), but the IPO date hasn’t been announced yet.<\/p>\n\n\n\n

In today’s article, we’ll discuss whether Candela shares<\/a> may be interesting for investors.<\/p>\n\n\n\n

<\/span><\/a>Business of Candela Medical, Inc.<\/span><\/h2>\n\n\n\n

The company has a rather longstanding business reputation. Candela was established in 1970 with a headquarters in Marlborough, Massachusetts. It currently employs almost 900 people.<\/p>\n\n\n\n

Candela Medical, Inc. has become the leading supplier of devices for aesthetic medicine. The company’s solutions have a vast scope of applications, for example, devices for laser microsurgery and dermatological platforms, such as Nordlys Multi-Application, which is used for treating different noncancerous vascular injuries.<\/p>\n\n\n\n

\"Business<\/a>
Business scheme of Candela Medical, Inc.<\/em><\/figcaption><\/figure>\n\n\n\n

Throughout its existence, Candela had four mergers, with Primaeva Medical, TransPharma Medical, Orscan Technologies, and CoolTouch, and created over 80 unique tools. The company’s non-material assets include more than 130 registered patents, while 55 more are now under development. Equipment developed by the company helped to lead 70 different clinical trials.<\/p>\n\n\n\n

As of 30 June 2021, Candela sold 45 thousand devices to 16 thousand clients all over the world. The customer retention rate is 48%, which is much higher than its competitors. The company works in 18 countries. Now let’s take a closer look at the issuer’s target market.<\/p>\n\n\n\n

<\/span><\/a>The market and competitors of Candela Medical, Inc.<\/span><\/h2>\n\n\n\n

Experts believe that the aesthetic market is expanding quite quickly. According to Markets&Research, the global aesthetic equipment market is estimated at $12 billion in 2021 and may reach $25 billion by 2028 with an average annual growth rate of 11%. Markets&Research thinks that over 100 million cosmetic surgeries and procedures will be carried out by the year-end of 2021.<\/p>\n\n\n\n

\"Aesthetic<\/a>
Aesthetic medicine market growth rate region-wise until 2028.<\/em><\/figcaption><\/figure>\n\n\n\n

The key reasons for the target market expansion will be:<\/p>\n\n\n\n